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Acute Physiologic Stress and Subsequent Anxiety
Among Family Members of ICU Patients
Sarah J. Beesley, MD1,2; Ramona O. Hopkins, PhD1,2,3; Julianne Holt-Lunstad, PhD3;
Emily L. Wilson, MStat1,2; Jorie Butler, PhD1,4; Kathryn G. Kuttler, PhD1,5; James Orme, MD1,2;
Samuel M. Brown, MD, MS1,2; Eliotte L. Hirshberg, MD, MS1,2,6
Objectives: The ICU is a complex and stressful environment and is
associated with significant psychologic morbidity for patients and
their families. We sought to determine whether salivary cortisol, a
physiologic measure of acute stress, was associated with subsequent psychologic distress among family members of ICU patients.
Design: This is a prospective, observational study of family members of adult ICU patients.
Center for Humanizing Critical Care, Intermountain Healthcare, Salt Lake
City, UT.
2
Pulmonary Division, Department of Medicine, Intermountain Medical Center, Murray, UT.
3
Neuroscience Center, Department of Psychology, Brigham Young University, Provo, UT.
4
Division of Geriatrics, Department of Internal Medicine, and Department
of Psychology, University of Utah, Salt Lake City, UT.
5
Homer Warner Center, Medical Informatics, Intermountain Healthcare,
Salt Lake City, UT.
6
Pediatric Critical Care, Department of Pediatrics, University of Utah, Salt
Lake City, UT.
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF
versions of this article on the journal’s website (http://journals.lww.com/
ccmjournal).
Drs. Hopkins, Kuttler, Orme, Brown, and Hirshberg contributed in conception; Drs. Beesley, Wilson, Kuttler, Brown, and Hirshberg contributed
in data acquisition; Drs. Beesley, Hopkins, Holt-Lunstad, Wilson, Brown,
and Hirshberg contributed in data analysis; Drs. Beesley, Hopkins, Brown,
and Hirshberg contributed in writing article; and all authors contributed in
revising article for important intellectual content and approval of final copy.
Supported, in part, by the Intermountain Research and Medical Foundation.
Dr. Hopkins’ institution received funding from the National Institutes of
Health (NIH)/National Heart, Lung, and Blood Institute, and she received
support for article research from the NIH. Dr. Butler disclosed government
work. The remaining authors have disclosed that they do not have any
potential conflicts of interest.
For information regarding this article, E-mail: Samuel.brown@imail.org;
ellie.hirshberg@imail.org
1

Copyright © 2017 The Author(s). Published by Wolters Kluwer Health, Inc.
on behalf of the Society of Critical Care Medicine and Wolters Kluwer
Health, Inc. This is an open-access article distributed under the terms
of the Creative Commons Attribution-Non Commercial-No Derivatives
License 4.0 (CCBY-NC-ND), where it is permissible to download and
share the work provided it is properly cited. The work cannot be changed
in any way or used commercially without permission from the journal.
DOI: 10.1097/CCM.0000000000002835

Critical Care Medicine

Setting: Adult medical and surgical ICU in a tertiary care center.
Subjects: Family members of ICU patients.
Interventions: Participants provided five salivary cortisol samples
over 24 hours at the time of the patient ICU admission. The primary
measure of cortisol was the area under the curve from ground; the
secondary measure was the cortisol awakening response. Outcomes were obtained during a 3-month follow-up telephone call.
The primary outcome was anxiety, measured by the Hospital Anxiety and Depression Scale-Anxiety. Secondary outcomes included
depression and posttraumatic stress disorder.
Measurements and Main Results: Among 100 participants, 92
completed follow-up. Twenty-nine participants (32%) reported
symptoms of anxiety at 3 months, 15 participants (16%) reported
depression symptoms, and 14 participants (15%) reported posttraumatic stress symptoms. In our primary analysis, cortisol level
as measured by area under the curve from ground was not significantly associated with anxiety (odds ratio, 0.94; p = 0.70). In our
secondary analysis, however, cortisol awakening response was
significantly associated with anxiety (odds ratio, 1.08; p = 0.02).
Conclusions: Roughly one third of family members experience
anxiety after an ICU admission for their loved one, and many family members also experience depression and posttraumatic stress.
Cortisol awakening response is associated with anxiety in family
members of ICU patients 3 months following the ICU admission.
Physiologic measurements of stress among ICU family members
may help identify individuals at particular risk of adverse psychologic outcomes. (Crit Care Med 2018; 46:229–235)
Key Words: family members; intensive care; postintensive care
syndrome; psychologic distress; salivary cortisol

T

he ICU is a complex and stressful environment with significant, unfavorable physical, cognitive, psychologic, and
functional consequences for both patients and families
(1–3). Patients who survive critical illness experience high rates of
anxiety, depression, and posttraumatic stress disorder (PTSD) that
persist months to years after hospital discharge (1). This constellation of psychologic morbidities is an important component of postintensive care syndrome (PICS) (4). Studies also demonstrate that
www.ccmjournal.org
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family members of ICU patients commonly suffer from psychologic disorders including persistent anxiety, depression, and PTSD
(2, 5–7) and may experience a decrease in quality of life that may
persist for 2 years or more (7). Such psychologic disorders among
ICU family members are characteristics of PICS-family (PICS-F)
(8) and are often associated with significant financial and emotional burden (9).
Multiple recent studies have begun to elucidate risk factors for PICS-F, including female sex, age of family member
or patient, history of anxiety, and amount of social support
(6, 7, 10). Family members also appear to be at higher risk for
persistent psychologic distress if they were involved in medical
decision-making or perceived that communication with clinicians was inadequate (2). Previous studies have not evaluated
whether physiologic markers of acute stress in the family members of adult patients are associated with subsequent PICS-F.
Evidence from other types of traumatic events (e.g., automobile collisions, combat exposure, psychosocial or workplace
stress, myocardial infarction) suggests that acute physiologic
stress may manifest in aberrations in the hypothalamus-pituitary axis (HPA) and may predispose an individual to persistent psychologic distress (11, 12). The HPA regulates the stress
response by modulating cortisol secretion (12), and physical,
emotional, and intellectual stresses are individually associated with alterations in the normal pattern of serum cortisol
secretion (13). Previous studies in non-ICU populations have
shown that cortisol secretion is elevated in patients with acute
and chronic anxiety (14, 15).
We sought to determine whether salivary cortisol measured
early in an ICU admission is associated with subsequent anxiety among ICU family members. We hypothesized that elevation in salivary cortisol would be associated with anxiety 3
months later among ICU family members.

METHODS
Study Participants
In a prospective cohort study, we enrolled adult family members of patients newly admitted to a multidisciplinary medical/
surgical ICU with an admission Acute Physiology and Chronic
Health Evaluation (APACHE) II (16) score greater than 15
(a score associated with at least a 10–20% hospital mortality
in contemporary environments). Study inclusion criteria were
ability to speak and read English. Participants were enrolled
within the first 24 hours of the patient’s ICU admission. Study
eligibility criteria excluded pregnant or breastfeeding females,
prisoners, and children (age < 18 yr) or a known history of
PTSD, dementia, or schizophrenia (17). Study participants
who used steroid-containing medications, which interfere with
cortisol secretion, were also excluded (18). To ensure enrollment within the acute phase of ICU exposure, family members
of patients who had been transferred from another ICU after
an inpatient stay longer than 24 hours or had a previous ICU
or long-term acute care hospital admission within the 90 days
prior to the index admission were also excluded. One study
participant per patient was eligible for study enrollment. If
230
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more than one family member was available, participants were
prioritized based on their relationship with the patient according to the algorithm depicted in Figure E1 (Supplemental
Digital Content 1, http://links.lww.com/CCM/D18), with preference for a spouse or family member living with the patient.
This study was approved by the Intermountain Medical Center
Institutional Review Board (number 1040305). Written consent
was obtained from all participants. Each participant received a
$50 gift card upon return of the cortisol samples, and another
$50 gift card on completion of the 3-month telephone interview.
Demographic Data
Demographic characteristics and medical history of study participants were obtained, including self-reported history of anxiety or depression and use of medications or substances known
to interfere with salivary cortisol secretion or collection (18). A
modified Perceived Stress Scale (PSS) was also collected at study
enrollment to record participant’s levels of perceived stress (19).
Characteristics of the ICU patient were also collected,
including admission APACHE II score, Elixhauser comorbidity score (20), age, sex, ICU and hospital length of stay, in-hospital mortality, and 3-month mortality, as well as the patient’s
number of prior ICU admissions in the last 5 years, based on
participant report.
Salivary Cortisol
We obtained five consecutive saliva samples from participants beginning the morning after study enrollment. Samples were obtained upon awakening and at prespecified time
intervals throughout the day (immediately upon awakening,
30 min post awakening and before breakfast, 30 min before
lunch, 30 minutes before dinner, and just before bedtime)
(21). Saliva samples were collected using a Salivette (Sarstedt
AG & Co, Nümbrecht, Germany), a sampling device for
measuring salivary cortisol. Participants were instructed to
follow standard protocol for salivary cortisol measurements
using the salivette (21). Samples were collected the next day
from participants by a research coordinator and stored at
–20°C until analysis (22). Cortisol levels were evaluated using
quantitative commercial enzyme immunoassay with chemiluminescence detection (chemiluminescence immunoassay;
IBL-Hamburg, Germany). The assay has a lower detection
limit of 0.1 nmol/L with intra- and interassay coefficients
of variation less than 8% (21). Cortisol via saliva sampling
has been shown to have high correlation (r = 0.90) with cortisol from serum and plasma samples (23). The area under
the curve with respect to ground (AUCg) was the prespecified primary measure of salivary cortisol (24). The AUCg
is an established method of reporting cortisol levels and is
obtained by calculating the area under the curve and above
the baseline (ground) when results are graphed over time
(for a sample calculation, see Fig. E2, Supplemental Digital
Content 1, http://links.lww.com/CCM/D18). We normalized the AUCg values for total time elapsed between the first
and last samples. Cortisol awakening response (CAR) was
a prespecified secondary measure of salivary cortisol. CAR
February 2018 • Volume 46 • Number 2
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represents the increase in cortisol level from the first (awakening) sample to the f ollowing sample 30 minutes later (25).
Cortisol values were excluded from analysis if any value was
greater than 3 sds from the mean of all samples for the entire
population or if the elapsed time between the first two samples (used to calculate the CAR) was greater than 90 minutes
(i.e., > 1 hr late). Participants’ data were excluded entirely from
analysis if they did not provide the cortisol samples necessary
to calculate either AUCg or CAR.
Outcome Instruments
The primary outcome was anxiety, assessed during a telephone
follow-up 3 months (± 1 mo) after enrollment, as measured by
the Hospital Anxiety and Depression Scale-Anxiety (HADSA) (26). The Hospital Anxiety and Depression Scale (HADS)
screens for anxiety and depression using a 14-item scale with
scores ranging from 0 to 21 for anxiety and depression; a HADS
score greater than or equal to 8 on either section is indicative of
possible or probable anxiety or depression, respectively (26). In
addition to the primary outcome, we also screened for depression (HADS-depression [HADS-D] [26]) and symptoms of
posttraumatic stress (Impact of Event Scale-Revised [IES-R]
[27]) during the 3-month follow-up. The IES-R is a 22-item
scale measuring intrusion, avoidance, and hyperarousal; a
mean score of greater than or equal to 1.6 indicates PTSD
symptoms (27).
Statistical Methods
Our prespecified primary analysis was a logistic regression
of AUCg on anxiety at 3 months, controlling for a history of
self-reported anxiety. In a prespecified secondary analysis, we
repeated the primary analysis, using the CAR instead of AUCg. We
also report secondary outcomes including depression (HADS-D
score ≥ 8) and symptoms of PTSD (IES-R score ≥ 1.6).
Sensitivity analyses were performed to determine whether
patient severity of illness or participant PSS altered the association between CAR and anxiety after correcting for a history of
self-reported anxiety. Sensitivity analyses were also conducted
to control for potentially relevant covariates using backward
stepwise logistic regression. In addition to our predictors of
interest (AUCg, CAR), candidate covariates included age, sex,
tobacco history, alcohol use, obesity, history of depression, history of anxiety, as well as whether the ICU patient had a previous ICU admission within the last 5 years. Covariates were
retained in the model using a backward stepwise feature selection strategy that optimized Akaike information criterion.
Sample Size and Power Calculation
The power calculation was performed assuming that the
mean estimated HADS-A score among individuals with minimal anxiety was 5 (± 2), while individuals with significant
anxiety had mean 8 (± 3). We therefore estimated, with 90%
power (alpha = 0.05), to detect a slightly more conservative
but still clinically important difference of 2 (26, 28) on the
HADS-A with 100 enrolled participants with a 15% attrition and a ratio of 1.5:1 in abnormal to normal AUCg (based
Critical Care Medicine

ICU Admissions with
APACHE II >15
1,031

137
Participants
eligible

251 (24%) Potential participants not assessed for
enrollment as another enrollment
happened the same day
213 (21%) Inclusion/Exclusion failure
150 (15%) Coordinator unavailable
132 (13%) No participant available to be enrolled
118 (11%) Out of enrollment window
30 (3%)
Investigator/Attending declined
36 (26%) Declined participation

101
Participants
enrolled

1 Participant withdrew
1 Participant withdrawn after determined to be ineligible
7 Participants did not follow up

92
Participants
completed
follow up

Figure 1. Flow diagram for study cohort. APACHE II = Acute Physiology
and Chronic Health Evaluation II.

on studies documenting the distribution of cortisol levels in
different populations) (29–31). Sample size calculations were
performed in PASS v12 (32).

RESULTS
Of 1,031 admissions to the study ICU, 137 (13%) had a family member eligible for the study and 100 participants were
enrolled; one participant withdrew after enrollment and before
completing study procedures. Ninety-two participants completed follow-up. See Figure 1 for consort diagram.
Participant Results
Study participants’ mean age was 54 (sd 14) years, and 64%
were female. The majority (71%) lived with the patient
prior to ICU admission, and 53% were the patient’s spouse.
A history of anxiety was self-reported by 26 participants
(26%). Mean (sd) PSS score at enrollment was 5 (4) and
was significantly higher for those with a history of anxiety
(4.5 vs 7.0; p = 0.002). Demographic information for study
participants are found in Table 1 with additional information available in Table E1 (Supplemental Digital Content 1,
http://links.lww.com/CCM/D18).
Patient Results
The ICU patients had a mean age of 60 (17) years, and 51%
were female. Mean APACHE II at admission was 30 (7). Fortyseven of these patients (47%) had been admitted to an ICU
within the last 5 years. In-hospital mortality was 21%. Further
detailed demographic and medical information for patients
are displayed in Table E2 (Supplemental Digital Content 1,
http://links.lww.com/CCM/D18).
Outcomes and Data Analysis
For all participants, median cortisol levels by normalized AUCg
were 3.9 nmol/L (interquartile range [IQR], 2.9–4.7) and by
CAR were 1.9 nmol/L (IQR, –2.3 to 8.1). Of the 92 participants
www.ccmjournal.org
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TABLE 1.

Study Participant Demographics

Variables

Cohort
(n = 99)

Age, mean ± sd

54 ± 14

Female sex, n (%)

63 (64)

Race, n (%)
American Indian or Alaskan Native

1 (1)

Asian

3 (3)

Black

2 (2)

Native Hawaiian or Pacific Islander

2 (2)

White

89 (90)

Not reported

2 (2)

Ethnicity, n (%)
Hispanic or Latino
Not Hispanic or Latino
Not reported

8 (8)
90 (91)
1 (1)

History of depression, n (%)

30 (30)

History of anxiety, n (%)

26 (26)

Perceived Stress Scale-4, mean ± sd

5±4

Relationship to patient, n (%)
Spouse

52 (53)

Patient is their parent

26 (26)

Patient is their child

11 (11)

Patient is their sibling

5 (5)

Other family relationship

4 (4)

Close friend

1 (1)

Live with patient, n (%)

70 (71)

Hours/wk with patient, n (%)
Full time (> 50 hr weekly or 8 hr daily)

52 (53)

Part time (11–50 hr a week or 3–5 hr daily)

29 (29)

< 10 hr a week (1–2 hr daily)

18 (18)

How much care providing to patient prior to
ICU admit, n (%)
None

52 (53)

Small amount

7 (7)

Moderate amount

18 (18)

Large amount

27 (27)

who completed follow-up, we had complete samples for AUCg
in 80 participants and for CAR in 77 participants, with seven
being excluded because more than 90 minutes elapsed between
the samples. No cortisol measurements were greater than 3 sds
from the mean.
232
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At 3-month follow-up, among the 92 participants with
recorded outcomes, 29 participants (32%) had HADS-A score
greater than or equal to 8 indicating possible or probable anxiety. Fifteen (16%) participants had HADS-D score greater than
or equal to 8, indicating possible or probable depression, and
14 participants (15%) had IES-R scores consistent with PTSD
(≥ 1.6). For our primary outcome, we used a dichotomous
assignment instead of continuous measures in all analyses due
to an influential outlier in HADS-A scoring.
In our primary analysis, normalized AUCg was not significantly associated with anxiety (odds ratio [OR], 0.94; CI,
0.69–1.26; p = 0.70), after controlling for a history of anxiety.
In the prespecified secondary analysis, however, CAR was significantly associated with anxiety (OR, 1.08; CI, 1.01–1.15;
p = 0.02) after controlling for a history of anxiety (Fig. 2). In
sensitivity analysis, CAR was also significantly associated with
3-month anxiety after controlling for the patient’s admission
APACHE II score and history of anxiety (OR, 1.08; CI, 1.01–
1.16; p = 0.02). CAR also remained significantly associated with
3-month anxiety after controlling for PSS and history of anxiety (1.09; CI, 1.02–1.17; p = 0.02). An effect plot which depicts
the relationship between predictor (CAR) and outcome (3-mo
anxiety) at different levels of the predictor while controlling
for a history of anxiety is represented in Figure 3. In a sensitivity analysis using backward stepwise logistic regression, the
association between CAR and anxiety remained significant
(OR, 1.10; CI, 1.03–1.18; p = 0.009) when controlling for other
relevant covariates (sex, history of anxiety, and previous ICU
admission) (Table 2).

DISCUSSION
In a prospective, observational study of family members of
ICU patients, the CAR, a measure of hypothalamic-pituitary
activation commonly associated with physiologic stress (33),
was associated with anxiety at 3 months. Although this finding
was a prespecified secondary analysis, the association between
CAR and anxiety persisted in sensitivity analyses that controlled for patient baseline severity of illness, a participant selfreported history of anxiety, and PSS scores at study enrollment.
The impact of a critical illness on family members of ICU
patients has received increasing recognition (6, 34). Many
questions remain about the best interventions, both in and
after the ICU, to ameliorate or prevent PICS-F and how to
identify those family members most at risk for PICS-F. To our
knowledge, ours is the first study in family members of adult
ICU patients investigating the link between an acute physiologic disturbance and subsequent anxiety.
Our results confirm the concept that a family member’s
vulnerability to anxiety after a loved one’s ICU admission is
comprised of both physiologic and psychologic characteristics.
Our findings additionally suggest that acute physiologic stress
(measured here by salivary cortisol) might identify individuals
at highest risk for post-ICU anxiety and raise the possibility
that reducing physiologic stress through specific support strategies may lessen post-ICU anxiety. CAR may serve as a physiologic indicator of identifying individuals who may respond
February 2018 • Volume 46 • Number 2
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Figure 2. Cortisol awakening response and 3-mo anxiety.

Figure 3. Effect plot for cortisol awakening response.

to support interventions during the ICU experience. Previous
studies of family members of chronically ill patients found that
providing communication and emotional support to family
members reduces anxiety (35, 36).
Critical Care Medicine

The ideal procedures for
measurement of physiologic
stress in ICU family members
remain unclear and are likely
dependent on the complex
relationship between acute
and chronic stress and cortisol secretion. High stress
can impair HPA functioning,
resulting in either chronically
elevated or blunted cortisol,
both of which may be linked
to important health outcomes
(37, 38). This blunting effect
may have been seen in the participants with chronic stress
in our study, possibly due to
a chronically ill loved one or
other stressors that were not
measured in this study. Within
each individual, the response
to stress is multifaceted and
variable—our results reflect
these complexities. Given that
this population is presumed
to be under acute stress, we
predicted an activated HPA
and elevated levels of salivary
cortisol (reflected in both an
increased AUCg and CAR) would predict later anxiety. The
CAR was associated with post-ICU anxiety in this population,
while our primary analysis using AUCg was nonsignificant. The
CAR and AUCg reflect discrete parts of the cortisol secretory
cycle (39); because the CAR is distinct from other earlier and
later circadian cortisol secretion, it may be more sensitive to
sleep quality (40)—a potentially salient influence in an ICU
setting.
We are unable with this study design to distinguish between
acute and chronic stress as causes of patterns of cortisol secretion. As indicated, 47% of participants had a family member
with a prior admission to an ICU and as such may have acute
stress superimposed on chronic stress. Research is needed to
understand the interplay between acute and acute-on-chronic
stress for ICU patients and their family members.
Our study has several potential limitations. First, as part of
a substudy, participants in this study were asked to leave the
patient’s room for additional testing. Some family members
declined the study, as they did not want to leave the patient’s
room, even for a short time, to meet with the research coordinator. It is possible that those family members have higher
stress, and they were not included in this study. This selection
bias may limit the generalizability of our findings. However, our
rates of declined consent were low, suggesting relatively minor
risk of bias. Owing to resource limitations, we were only able to
enroll one participant per day, as such many potentially eligible
participants were not approached. We do not believe that the
www.ccmjournal.org
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Multivariate Backwards Stepwise
Logistic Regression of Hospital Anxiety
and Depression Scale-Anxiety
TABLE 2.

Variables

OR (95% CI)

p

Cortisol awakening
response

1.10 (1.03–1.18)

0.009

Female

3.59 (0.99–15.93)

0.07

History of anxiety

6.70 (1.89–26.69)

0.004

Previous ICU admit

3.04 (0.94–10.87)

0.07

OR = odds ratio.
Boldface values indicate p < 0.05.

process of approaching participants introduced systematic bias,
as coordinators approached family members without any preferences for patient or participant types.
We did not collect detailed data on participant’s other
potential stressors or baseline medical history, so we may have
missed some factors that may influenced the cortisol values
and study outcomes. Additionally, it is possible that some participants did not accurately record the timing of their cortisol
collection, and our results may have been skewed by inaccurate
salivary cortisol data. However, no values in our participants
were outside the expected range, suggesting that such an effect
was unlikely. To reduce the burden on family members, we only
collected salivary cortisol samples on 1 day and thus did not
capture intraindividual fluctuations in CAR (41). Finally, we
did not measure sleep or sleep quality (42) or regulate all substances and habits known to interact with cortisol secretion.
Family members of ICU patients are a select population
vulnerable to long-term effects from the stress precipitated by
a loved one’s critical illness. Not all family members develop
PICS-F, and identification of at-risk individuals is a key aspect
of interventions to prevent or ameliorate the morbidities associated with this syndrome. We identified elevated CAR as a
predictor of subsequent anxiety in family members of adult
ICU patients. This study is a novel, important step in characterizing physiologic processes that could allow for early targeted therapies to mitigate post-ICU anxiety.
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